Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

ncing activities in the 2012 period reflect the private placement completed in February 2012. The cash flows from financing activities in the 2013 period reflect the direct placement to OrbiMed completed in February 2013, as well as funding under the share purchase agreement with Lincoln Park Capital.

Conference Call and Webcast InformationBioLineRx will hold a conference call to discuss its third quarter 2013 results today, November 13, 2013, at 10:00 a.m. EST. The conference call will be available via webcast and can be accessed through the Investor Relations section of BioLineRx's website, www.biolinerx.com, and through www.kcsa.com. A presentation will be provided on BioLineRx's website to accompany management's remarks during the conference call. To dial into the conference call, please dial 1-888-281-1167 from the U.S. or +972-3-918-0685 internationally. A replay of the conference call will be available approximately two hours after completion of the live conference call at www.biolinerx.com or www.kcsa.com. A dial-in replay of the call will also be available until November 16, 2013. To access the replay, please dial 1-888-254-7270 from the U.S. or +972-3-925-5927 internationally.

(Tables follow)About BioLineRxBioLineRx is a publicly-traded biopharmaceutical development company dedicated to building a portfolio of products for unmet medical needs, as well as those with advantages over currently available therapies. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's current portfolio consists of a variety of clinical and pre-clinical projects, including:
'/>"/>

SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... the "Home Healthcare Global Market - Forecast to ... home healthcare market is expected to reach more than ... The home healthcare equipment market is expected ... healthcare services market. Home healthcare is gaining a tremendous ...
(Date:5/5/2015)... Calif. , May 5, 2015  Accuray Incorporated ... to present at the Bank of America Merrill Lynch ... on Tuesday, May 12, 2015 at 2:20pm PT. ... will be available on the Investor Relations page of ... replay of the presentation will begin approximately one hour ...
(Date:5/5/2015)... May 5, 2015 E-QURE (Electric ... "Company"), a premier provider of innovative medical devices in ... an update to shareholders and the investment community, covering ... acquisition of the proprietary Bioelectrical Signal Therapy™ (BST) Device ... its S-1, as well as its plans for commercialization ...
Breaking Medicine Technology:Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5
... N.J., Jan. 4, 2012  The Musculoskeletal Transplant Foundation (MTF) has ... FLEX HD® bi-lateral breast kits. The new sizes--16cm x 20cm ... the needs of surgeons and their patients. This unique human ... reconstruction. It has been a year since ...
... IRIDEX Corporation (Nasdaq: IRIX ) today announced that ... at the Sidoti & Company, LLC Annual New York Micro ... Time.  The one-day conference is being held at the Grand ... IRIDEX IRIDEX Corporation was founded in 1989 ...
Cached Medicine Technology:New, Larger, Bilateral Breast Graft Kits Announced by MTF 2
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the ... global research, outreach and patient advocacy programs. The gala evening ... that attracted hundreds of supporters. , The 2015 gala was ... hepatitis B virus (HBV) by Dr. Baruch S. Blumberg, who ... in Medicine for his discovery of the virus in 1976. ...
(Date:5/5/2015)... Baptist Medical Center Jacksonville’s cancer program has received ... American College of Surgeons. , To earn the three-year ... Commission on Cancer quality care standards, be evaluated every ... of excellence in the delivery of comprehensive patient-centered care. ... locally at a CoC-accredited cancer center, they are gaining ...
(Date:5/5/2015)... QuickPick Travel ” was featured on NewsWatch as part of ... and large businesses making an impact in their industry. Susan ... the business review and shared with viewers how this is ... vacation for free. , Vacations are a sought-after opportunity to ... when people are preparing for vacations, they’re used to getting ...
(Date:5/5/2015)... ProTexting, LLC – a premier SMS ... Engagement Campaigns and other Mobile solutions, introduces e-mail integration ... leverage the power of Mobile Marketing to expand their ... addresses into the Constant Contact Platform. , ProTexting CEO, ... trend of multi-channel marketing would become more prominent in ...
(Date:5/5/2015)... Orange, New Jersey (PRWEB) May 05, 2015 ... system, today announced the launch of a new healthy ... Talbot, a season two semi-finalist on Bravo’s Top Chef, ... dishes that promote wellness and healthy living. In ... an enhanced Wellness Website and the videos will be ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... global emergency. It challenges the ability and will of ... policy mix to foster //the health of the vast ... an acknowledged expert and a rebel among Indian physicians. ... show that Mycobacterium tuberculosis Hominis (MTB) (the scientific term ...
... agents to lower cholesterol and the associated risks// of ... have proapoptotic and antimetastatic effects in cancer. In fact, ... colorectal cancers, but others to include epidemiologic ones have ... over 30,000 men in a longitudinal health study with ...
... study complied by addiction specialists and published in Lancet Medical ... class A drugs. Prof David Nutt from Bristol University headed ... as the fifth most dangerous drug followed by ketamine, speed ... Cannabis is less harmful than tobacco and is recently downgraded ...
... A recent study finds that improving the institutional culture ... strong impact on bad habits like// smoking, drinking, drug ... London School of Hygiene and Tropical Medicine's Centre for ... misuse and teenage pregnancy are major public health challenges ...
... order to increase their efficiency in UK. // ,A ... hours alone is not enough to reduce exhaustion and that ... ,The Occupational and Environmental Medicine journal study was conducted by ... ,In the UK, junior doctors will have to work ...
... texts of Siddha system of medicine into English is on the ... the texts, contained in palm leaf manuscripts, would be published ... Indian state of Tamil Nadu. ,As many ... of the state government for two years and produced six volumes, ...
Cached Medicine News:Health News:Tuberculosis, A Challenge To The Political Will Of Governments, Says Veteran Crusader 2Health News:Tuberculosis, A Challenge To The Political Will Of Governments, Says Veteran Crusader 3Health News:Statin Drugs and Risk of Advanced Prostate Cancer 2Health News:Improve School Ethos to Combat Teen Evils 2Health News:Rest for Doctors to Ensure Patients’ Safet 2
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... of mini-cells has always distinguished itself ... The tradition continues with the patented ... a gel tension wedge in place ... earlier models makes the XCell SureLock ...
... GeneMachines Hyb4 is built upon the success ... The unit automates all thermal and wash ... on standard glass slides. A 4-position ... hybridized, while the individual ports allow for ...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Medicine Products: